Risk of Congenital Heart Defects in Offspring of Affected Mothers and Fathers
- PMID: 35608601
- PMCID: PMC9384828
- DOI: 10.1161/CIRCGEN.121.003533
Risk of Congenital Heart Defects in Offspring of Affected Mothers and Fathers
Abstract
Background: Smaller studies have reported a higher offspring risk of congenital heart defects (CHDs) for mothers with CHDs than for fathers with CHDs. In a large population-based study, we investigated whether offspring risk of CHD differed for mothers and fathers with CHDs.
Methods: All people born in Denmark, 1977 to 2011, with at least 1 registered parent, were included in our cohort (n=2 341 061). Parent-child recurrence of CHDs was evaluated using risk ratios (RRs) comparing risks of CHDs in individuals with and without a parent with a CHD, estimated using log-linear binomial regression.
Results: The RRs for any CHD in offspring were 5.39 (95% CI, 4.88-5.96) for mothers and 3.04 (95% CI, 2.59-3.57) for fathers affected with any CHD; the ratio of RRs for mothers versus fathers was 1.82 (P<0.0001). Recurrence RRs for the same cardiac phenotype in parent and offspring were significantly stronger for mothers than for fathers for conotruncal defects (ratio of RRs, 4.98), left ventricular outlet tract obstruction (ratio of RRs, 4.98), and ventricular septal defects (ratio of RRs, 2.51) but not for atrioventricular septal defects (ratio of RRs, 1.06). Birth rates among people with CHDs, relative to the general population, were 18% higher for women than for men, regardless of parental cardiac phenotype.
Conclusions: Recurrence risks of CHDs were significantly greater in the offspring of affected women than in the offspring of affected men. The excess maternal recurrence risks could not be explained by the slightly higher birth rates in women with CHDs.
Keywords: birth rate; cohort studies; epidemiology; genetics; heart defects, congenital; population; risk.
Figures



Comment in
-
Familial Aggregation Studies: A Valuable Tool in the Genetic Toolbox.Circ Genom Precis Med. 2022 Aug;15(4):e003868. doi: 10.1161/CIRCGEN.122.003868. Epub 2022 Aug 2. Circ Genom Precis Med. 2022. PMID: 35917284 No abstract available.
References
-
- Pierpont ME, Brueckner M, Chung WK, Garg V, Lacro RV, McGuire AL, Mital S, Priest JR, Pu WT, Roberts A, et al. ; American Heart Association Council on Cardiovascular Disease in the Young; Council on Cardiovascular and Stroke Nursing; and Council on Genomic and Precision Medicine. Genetic basis for congenital heart disease: revisited: a scientific statement from the American Heart Association. Circulation. 2018;138:e653–e711. doi: 10.1161/CIR.0000000000000606 - PMC - PubMed
-
- Baumgartner H, De Backer J, Babu-Narayan SV, Budts W, Chessa M, Diller GP, Lung B, Kluin J, Lang IM, Meijboom F, et al. ; ESC Scientific Document Group. 2020 ESC guidelines for the management of adult congenital heart disease. Eur Heart J. 2021;42:563–645. doi: 10.1093/eurheartj/ehaa554 - PubMed
-
- Nora JJ, Nora AH. Maternal transmission of congenital heart diseases: new recurrence risk figures and the questions of cytoplasmic inheritance and vulnerability to teratogens. Am J Cardiol. 1987;59:459–463. doi: 10.1016/0002-9149(87)90956-8 - PubMed
-
- Burn J, Brennan P, Little J, Holloway S, Coffey R, Somerville J, Dennis NR, Allan L, Arnold R, Deanfield JE, et al. . Recurrence risks in offspring of adults with major heart defects: results from first cohort of British collaborative study. Lancet. 1998;351:311–316. doi: 10.1016/s0140-6736(97)06486-6 - PubMed
-
- Øyen N, Poulsen G, Boyd HA, Wohlfahrt J, Jensen PK, Melbye M. Recurrence of congenital heart defects in families. Circulation. 2009;120:295–301. doi: 10.1161/CIRCULATIONAHA.109.857987 - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical